Durect(us:DRRX)

0.8020

0.00%

Updated on 2025-04-02

Open:0.8000
Close:0.8020
High:0.8049
Low:0.8000
Prev Close:0.8020
Volume:46499.00
Turnover:37233.62
Turnover Ratio:0.15%
Shares:31.04M
MarketCap:24.90M

About Durect

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Company Name: Durect
Address: 10240 Bubb Road
Employees: 58
Fiscar Year: 12-31
IPO Date: 2000-09-28
CIK: 1082038

View all SEC Filings

About

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Address:10240 Bubb Road

Market Movers